We describe the use of peripheral veno-venous extracorporeal membrane oxygenation (VV ECMO) and high-flow nasal oxygen as procedural support in a patient undergoing debulking of a malignant tumour of the lower airway. Due to the significant risk of complete airway obstruction upon induction of anaesthesia, ECMO was established while the patient was awake, and was maintained without systemic anticoagulation to minimise the risk of intraoperative bleeding. This case illustrates that ECMO support with high-flow nasal oxygen can be considered as part of the algorithm for airway management during surgery for subtotal lower airway obstruction, as it may be the only viable option for maintaining adequate gas exchange.
Introduction
The use of extracorporeal membrane oxygenation (ECMO) as procedural support to maintain adequate gas exchange in patients undergoing surgery for lower airway obstruction is a relatively novel approach which merits increased attention within the anaesthetic community, particularly if used with high-flow nasal oxygen. We present a case of tracheal melanoma deposits causing severe distal tracheal stenosis, where adequate gas exchange during surgical resection was facilitated by veno-venous (VV) ECMO and high-flow nasal oxygen. The educational objective of this report is to highlight the utility of ECMO and adjunctive high-flow apnoeic oxygenation in patients who are at prohibitive risk of complete airway obstruction with conventional management. Written consent for publication of this case was obtained from the patient's next of kin.
Case history
A 73-year-old female presented with severe breathlessness due to subtotal obstruction of the distal trachea by melanoma metastases. She was unable to walk more than ten metres and had marked orthopnoea. The patient had previously undergone multiple extensive surgeries for locally invasive primary sinonasal melanoma, including partial maxillectomy and orbital decompression. She had also received an abbreviated course of radiotherapy, which was discontinued due to local toxicity. Subsequently (two months before presentation), she had undergone laryngobronchoscopy and debulking of metastatic melanoma deposits that had seeded in her trachea. Supraglottic jet ventilation was used during the procedure, however she was much less symptomatic at that time. On examination, she had stridor at rest and marked use of accessory muscles of ventilation. A computed tomography scan (two months after the initial debulking procedure) revealed an intraluminal tracheal lesion and tracheal wall thickening suggestive of recurrent metastatic disease.
Repeat laryngobronchoscopy and debulking of her tracheal melanoma deposits was planned to palliate her symptoms. Because the patient was considered to be at prohibitive risk of complete airway obstruction with conventional anaesthetic management, her case was discussed by a multidisciplinary team that included anaesthesia, perfusion, ear, nose and throat surgery and cardiothoracic surgery. Several options for airway management were considered including: a) Supraglottic jet ventilation, with VV ECMO on standby that could be instituted emergently in the case of intraoperative airway compromise; b) Supraglottic jet ventilation and pre-induction placement of groin sheaths for rapid access (rewiring) of ECMO cannulae if required; or c) Electively placing the patient on VV ECMO before induction and maintaining ECMO for the duration of the procedure, with or without supraglottic jet ventilation.
Ultimately, the consensus was that performing the debulking procedure with elective VV ECMO and high-flow nasal oxygen support established before induction would be the only clinically viable option.
Prior to surgery, high-flow humidified oxygen was established via nasal prongs into a single nostril at 50 l/minute (transnasal humidified rapid-insufflation ventilator exchange [THRIVE], Fisher and Paykel, Auckland, New Zealand), as the patient had previously undergone unilateral nasal surgery. The patient was administered midazolam (1 mg) and fentanyl (50 μg), a radial arterial line was inserted and a remifentanil infusion was commenced (Minto Model, effect-site concentration target (Cet) 0.5-1.5 ng/ml). On high-flow nasal oxygen alone, arterial blood gas analysis revealed a PaO 2 of 568 mmHg and PaCO 2 of 43 mmHg. Following a heparin bolus of 5000 units, which increased the activated clotting time from 120 to 294 seconds, ECMO cannulation was performed using local anaesthesia and ultrasound guidance. A 21-Fr drainage cannula (Venous HLS cannula, Maquet Cardiopulmonary, Rastatt, Germany) was inserted into the left common femoral vein to 40 cm and a 21-Fr return cannula (Venous Bio-Medicus cannula, Medtronic, MN, USA) was inserted into the right common femoral vein with the tip placed in a more proximal position to 45 cm. This procedure was performed in reverse Trendelenburg position (approximately 30 degrees) due to marked orthopnoea.
ECMO support was established with an initial flow rate of 2.5 l/minute. The ECMO circuit consisted of a membrane oxygenator (PLS-i, Maquet Cardiopulmonary, Hirrlingen, Germany), centrifugal pump (Rotaflow, Maquet Cardiopulmonary, Hirrlingen, Germany) and heparin-coated tubing (Bioline-coating Permanent Life Support Set Plus, Maquet Cardiopulmonary, Rastatt, Germany). Subsequently, anaesthesia was induced with propofol (Schnider Model, Cet 3 μg/ml) and the rate of the remifentanil infusion was increased to a Cet of 2 ng/ml. Rocuronium (40 mg) was used for muscle relaxation. Anaesthesia was maintained with total intravenous anaesthesia, with propofol and remifentanil infusions titrated to a bispectral index of 40-50. Prior to the start of surgery, protamine (50 mg) was administered, which returned the activated clotting time towards baseline (124 seconds). The rationale for reversing the anticoagulant effect of heparin was to minimise bleeding during surgical debridement of the airway deposits.
At laryngobronchoscopy, multiple tracheal deposits were found to be causing near complete obstruction of the distal tracheal lumen (Figure 1 ). These were removed with a Straightshot M4 Microdebrider (Medtronic ENT, Jacksonville, FL, USA) attached to a 2.9 mm angle-tip Skimmer Blade (Medtronic Xomed, Jacksonville, FL, USA), and haemostasis was achieved with topical adrenaline on neuropatties (Codman, Raynham, MA, USA) as well as topical Floseal Hemostatic Matrix (Baxter, Hayward, CA, USA). Initially, ECMO flow rates of only 2 to 3 l/minute could be achieved and the patient's arterial oxygen saturation drifted down to 88% after about 30 minutes (PaO 2 of 52 mmHg and PaCO 2 of 33 mmHg). This improved after an intravenous fluid bolus allowed the ECMO flow rate to be increased above 3 l/minute, and arterial oxygen saturation remained between 96% and 99% thereafter. THRIVE was continued throughout the procedure to provide apnoeic oxygenation as an adjunct to ECMO. Carbon dioxide was monitored by arterial blood gas sampling and remained within the range of 29 mmHg to 40 mmHg. The patient remained haemodynamically stable both upon commencement of VV ECMO and throughout the procedure.
At the conclusion of the procedure, total intravenous anaesthesia was ceased and sugammadex (200 mg) was administered. When the patient recommenced spontaneous breathing, ECMO support and high-flow nasal oxygen were weaned. Arterial blood gas analysis on room air revealed a PaO 2 of 66 mmHg and PaCO 2 of 40 mmHg. Nebulised adrenaline (1:10,000, 5 ml) was administered as an adjunct for haemostasis of the resected lesions and the patient was placed on supplemental oxygen at 6 l/minute via a Hudson mask. She was then decannulated from ECMO. She made an uneventful recovery and was discharged home the next day. The patient had significant symptomatic relief postoperatively, but eventually succumbed to her underlying disease about four months later.
Discussion
This case report illustrates the utility of VV ECMO and highflow nasal oxygen in the perioperative management of severe tracheal obstruction. Together, they provided adequate oxygenation and removal of carbon dioxide despite apnoea, while allowing the surgeon to have an unobstructed and motionless view of the airway.
Conventional options for airway management in this case included intubation with preservation of spontaneous ventilation, apnoea with intermittent bag-mask ventilation, use of a ventilating bronchoscope, and jet or spontaneous ventilation with suspension laryngoscopy 1 . However, in our patient, all of these techniques carried an unacceptably high risk of complete airway obstruction upon induction of anaesthesia due to the severity of her lower airway obstruction. Furthermore, endotracheal intubation could have traumatised the tumour, causing it to bleed and/or fragment 2 . Jet ventilation via suspension laryngoscopy, which was used during her first debulking procedure, may be complicated by barotrauma, pneumothorax, hypo-or hyperventilation and gastric insufflation 3 .
We believe that the concurrent use of high-flow nasal oxygen was a useful adjunct in our case because the ECMO flow rates that could be achieved initially were too low to provide adequate oxygenation. As a rule of thumb, VV ECMO flows of greater than 60% of cardiac output are required to maintain systemic oxygen saturation >90% 4 . The use of high-flow nasal oxygen significantly increased the duration of apnoeic oxygenation 5 , although it is likely to have been most efficacious during the early stages of the procedure (before near complete tracheal obstruction ensued during surgery), and when weaning our patient from ECMO support. Moreover, while high-flow nasal oxygen provided an additional margin of safety in our patient, as an alternative, we could have inserted another venous drainage cannula in the superior vena cava to facilitate high ECMO flow rates. However, this would have been poorly tolerated while the patient was awake, due to her marked orthopnoea.
To date, there is limited literature on the elective use of ECMO for thoracic surgical support. Other cases include the use of ECMO in patients undergoing complex tracheooesophageal fistula repair following pneumonectomy 6 , resection of papillomatous obstruction of the trachea 7 and lung lavage for pulmonary alveolar proteinosis 8 .
In contrast to veno-arterial ECMO, which provides both cardiac and respiratory support, VV ECMO causes much less major morbidity such as limb ischaemia and bleeding which may result from arterial cannulation 9 . Moreover, while ECMO triggers a systemic inflammatory response (mediated by neutrophil and complement activation) due to blood coming into contact with non-endothelial surfaces, this is much less pronounced than occurs during cardiopulmonary bypass (CPB) 10, 11 . There is no venous reservoir in an ECMO circuit, thereby reducing the surface area of the circuit and eliminating the exposure of blood to air 12 . ECMO circuits are also coated with heparin, which significantly decreases the requirement for systemic anticoagulation compared to CPB 13 . Low-level anticoagulation with heparin (to an activated partial thromboplastin time of 50 to 70 seconds) is adequate for patients on prolonged ECMO support to prevent thrombus formation within the circuit 14 . In our case, we elected to reverse the heparin bolus given prior to cannulation to minimise the risk of bleeding during the debulking procedure. Although this would have shortened the lifespan of the ECMO circuit, which is usually about 1-3 weeks, this is not an issue for short-term procedural support.
Finally, the additional costs incurred in this case were for ECMO disposables (approximately A$4,000) and for the extra personnel involved.
Conclusion
In recent years ECMO has emerged as a highly versatile treatment modality, not only in the intensive care setting as rescue therapy for refractory respiratory and/or cardiac failure, but also as procedural support for anaesthesia and surgery. This case illustrates how with multidisciplinary input, a patient who was at extremely high risk of complete airway obstruction upon induction of anaesthesia could be safely managed with VV ECMO and high-flow nasal oxygen support without systemic anticoagulation. ECMO and adjunctive apnoeic oxygenation should be considered as part of the algorithm for airway management and maintenance of adequate gas exchange in patients requiring surgery for subtotal lower airway obstruction.
